| Bassam Syed Shakil, MD | |
|
655 S Dobson Rd Ste 214, Building B, Suite 214, Chandler, AZ 85224-5671 | |
| (480) 857-2381 | |
| (480) 857-2407 |
| Full Name | Bassam Syed Shakil |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 15 Years |
| Location | 655 S Dobson Rd Ste 214, Chandler, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790915684 | NPI | - | NPPES |
| 892822 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 48780 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chandler Dialysis (fmc) | Chandler, AZ | Dialysis facility |
| Sun Lakes Dialysis (fmc) | Sun lakes, AZ | Dialysis facility |
| Chandler Regional Medical Center | Chandler, AZ | Hospital |
| Mercy Gilbert Medical Center | Gilbert, AZ | Hospital |
| Banner Baywood Medical Center | Mesa, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Akdhc Llc | 8123912136 | 124 |
News Archive
GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.
ARIAD Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 16,000,000 shares of its common stock at $3.70 per share. The offering is expected to close on or about October 29, 2010, subject to customary closing conditions. In addition, ARIAD has granted the underwriters a 30-day option to purchase up to 2,400,000 shares of common stock to cover over-allotments, if any.
Companies developing new drugs for the global market must deal with the rising costs of the R&D process – and outsourcing may well be the best route. That's the verdict of Dr Faiz Kermani, a specialist in outsourcing and research development for the pharmaceutical industry.
Robert Zucker, Ph.D., director of the University of Michigan Addiction Research Center, and the Substance Abuse Section in the Department of Psychiatry, has been named recipient of the 31st annual Research Society on Alcoholism Distinguished Researcher Award. The award is given to an individual whose research has made significant contributions to the understanding of alcohol abuse and alcoholism, and whose body of work demonstrates leadership in the field.
› Verified 9 days ago
| Entity Name | Akdhc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316902208 PECOS PAC ID: 8123912136 Enrollment ID: O20040211000250 |
News Archive
GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.
ARIAD Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 16,000,000 shares of its common stock at $3.70 per share. The offering is expected to close on or about October 29, 2010, subject to customary closing conditions. In addition, ARIAD has granted the underwriters a 30-day option to purchase up to 2,400,000 shares of common stock to cover over-allotments, if any.
Companies developing new drugs for the global market must deal with the rising costs of the R&D process – and outsourcing may well be the best route. That's the verdict of Dr Faiz Kermani, a specialist in outsourcing and research development for the pharmaceutical industry.
Robert Zucker, Ph.D., director of the University of Michigan Addiction Research Center, and the Substance Abuse Section in the Department of Psychiatry, has been named recipient of the 31st annual Research Society on Alcoholism Distinguished Researcher Award. The award is given to an individual whose research has made significant contributions to the understanding of alcohol abuse and alcoholism, and whose body of work demonstrates leadership in the field.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bassam Syed Shakil, MD 6622 N 91st Ave Ste 220, Glendale, AZ 85305-2569 Ph: (602) 759-6883 | Bassam Syed Shakil, MD 655 S Dobson Rd Ste 214, Building B, Suite 214, Chandler, AZ 85224-5671 Ph: (480) 857-2381 |
News Archive
GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.
ARIAD Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 16,000,000 shares of its common stock at $3.70 per share. The offering is expected to close on or about October 29, 2010, subject to customary closing conditions. In addition, ARIAD has granted the underwriters a 30-day option to purchase up to 2,400,000 shares of common stock to cover over-allotments, if any.
Companies developing new drugs for the global market must deal with the rising costs of the R&D process – and outsourcing may well be the best route. That's the verdict of Dr Faiz Kermani, a specialist in outsourcing and research development for the pharmaceutical industry.
Robert Zucker, Ph.D., director of the University of Michigan Addiction Research Center, and the Substance Abuse Section in the Department of Psychiatry, has been named recipient of the 31st annual Research Society on Alcoholism Distinguished Researcher Award. The award is given to an individual whose research has made significant contributions to the understanding of alcohol abuse and alcoholism, and whose body of work demonstrates leadership in the field.
› Verified 9 days ago
Dr. Jaskanwal Singh Bisla, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1955 W Frye Rd, Chandler, AZ 85224 Phone: 480-428-5500 | |
Dr. Naga Nalini Tirumalasetty, MD,ECNU,FACE. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 908 W Chandler Blvd Ste 4, Chandler, AZ 85225 Phone: 480-269-6448 Fax: 779-204-2331 | |
Amer Al-khoudari, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 604 W Warner Rd Ste C1, Chandler, AZ 85225 Phone: 480-372-8200 Fax: 480-372-8222 | |
Bidya Lohani-sharma, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 845 E Warner Rd Ste 101, Chandler, AZ 85225 Phone: 480-786-5000 Fax: 480-786-5050 | |
Nisar Ahmed, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3115 S Price Rd, Chandler, AZ 85248 Phone: 480-926-0170 Fax: 480-452-0715 | |
Chuck Stephen Mangubat, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3115 S Price Rd, Chandler, AZ 85248 Phone: 480-926-0170 Fax: 480-452-0715 | |
Dr. Edward Markman, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 475 S Dobson Rd, Chandler, AZ 85224 Phone: 480-926-0170 |